These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29921453)

  • 41. New chapter on CKD highlights changes to 15th annual USRDS report.
    Nephrol News Issues; 2003 Nov; 17(12):25-8, 110. PubMed ID: 14640007
    [No Abstract]   [Full Text] [Related]  

  • 42. Terminal care of the ESRD patient foregoing life-sustaining dialysis therapy.
    Campbell ML
    ANNA J; 1991 Apr; 18(2):202-4. PubMed ID: 2025052
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methods of ESRD treatment.
    Am J Kidney Dis; 1991 Nov; 18(5 Suppl 2):38-48. PubMed ID: 1951356
    [No Abstract]   [Full Text] [Related]  

  • 44. [Chronic renal failure, a frequent and asymptomatic pathology].
    Hummel A
    Soins; 2010 May; (745):24-6. PubMed ID: 20509485
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An innovative strategy to effectively prevent ESRD.
    Futrakul P; Futrakul N
    Am J Kidney Dis; 2008 Jan; 51(1):162; author reply 162-3. PubMed ID: 18155548
    [No Abstract]   [Full Text] [Related]  

  • 46. Current status of dialysis and vascular access in Taiwan.
    Chen CF; Chen FA; Lee TL; Liao LF; Chen CY; Tan AC; Chan CH; Lin CC
    J Vasc Access; 2019 Jul; 20(4):368-373. PubMed ID: 30354908
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Percentage of deaths drops despite steady growth in ESRD population.
    Nephrol News Issues; 1995 Sep; 9(9):15-6. PubMed ID: 7501028
    [No Abstract]   [Full Text] [Related]  

  • 48. The 2011 ESRD prospective payment system: perspectives from a for-profit small- to medium-sized dialysis organization.
    Bhat P; Bhat JG
    Am J Kidney Dis; 2011 Apr; 57(4):556-8. PubMed ID: 21316132
    [No Abstract]   [Full Text] [Related]  

  • 49. What would Scrib think about our progress in dialysis care?
    Blagg CR
    Nephrol News Issues; 2011 Aug; 25(9):8. PubMed ID: 21905523
    [No Abstract]   [Full Text] [Related]  

  • 50. The 2011 ESRD prospective payment system: perspectives from DaVita, a for-profit large dialysis organization.
    Nissenson AR; Mayne TJ; Krishnan M
    Am J Kidney Dis; 2011 Apr; 57(4):550-2. PubMed ID: 21333425
    [No Abstract]   [Full Text] [Related]  

  • 51. The 2011 ESRD prospective payment system: an uncontrolled experiment.
    Winkelmayer WC; Chertow GM
    Am J Kidney Dis; 2011 Apr; 57(4):542-6. PubMed ID: 21333428
    [No Abstract]   [Full Text] [Related]  

  • 52. Pre-ESRD Depression and Post-ESRD Mortality in Patients with Advanced CKD Transitioning to Dialysis.
    Molnar MZ; Streja E; Sumida K; Soohoo M; Ravel VA; Gaipov A; Potukuchi PK; Thomas F; Rhee CM; Lu JL; Kalantar-Zadeh K; Kovesdy CP
    Clin J Am Soc Nephrol; 2017 Sep; 12(9):1428-1437. PubMed ID: 28679562
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Palliative care in ESRD.
    Nephrol News Issues; 2003 Feb; 17(3):43-5, 49-50. PubMed ID: 12655998
    [No Abstract]   [Full Text] [Related]  

  • 54. The organization and financing of kidney dialysis and transplant care in the United States of America.
    Hirth RA
    Int J Health Care Finance Econ; 2007 Dec; 7(4):301-18. PubMed ID: 17602296
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Annual facility survey of providers of ESRD therapy. United States Renal Data System.
    Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S132-5. PubMed ID: 9713415
    [No Abstract]   [Full Text] [Related]  

  • 56. Commentary on 'The DOPPS practice monitor for US dialysis care: trends through April 2011': no surprises yet.
    Winkelmayer WC; Weiner DE
    Am J Kidney Dis; 2012 Feb; 59(2):312-4. PubMed ID: 22243946
    [No Abstract]   [Full Text] [Related]  

  • 57. Conservative Management and End-of-Life Care in an Australian Cohort with ESRD.
    Morton RL; Webster AC; McGeechan K; Howard K; Murtagh FEM; Gray NA; Kerr PG; Germain MJ; Snelling P
    Clin J Am Soc Nephrol; 2016 Dec; 11(12):2195-2203. PubMed ID: 27697783
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Polycystic kidney disease at end-stage renal disease in the United States: patient characteristics and survival.
    Abbott KC; Agodoa LY
    Clin Nephrol; 2002 Mar; 57(3):208-14. PubMed ID: 11924752
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thrombotic microangiopathy in United States long-term dialysis patients.
    Perkins RM; Reynolds JC; Ahuja TS; Reid T; Agodoa LY; Bohen EM; Yuan CM; Abbott KC
    Nephrol Dial Transplant; 2006 Jan; 21(1):191-6. PubMed ID: 16204286
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vascular access: new approaches needed for a more complex ESRD population.
    Spergel LM
    Nephrol News Issues; 1997 Feb; 11(2):30-1, 34. PubMed ID: 9096462
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.